| Dr Michael Stephen Wilberger, MD | |
|
345 Blackstone Blvd, Providence, RI 02906-4800 | |
| (401) 455-6200 | |
| (401) 455-6309 |
| Full Name | Dr Michael Stephen Wilberger |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 345 Blackstone Blvd, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114933496 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Stephen Wilberger, MD 345 Blackstone Blvd, Providence, RI 02906-4800 Ph: (401) 455-6200 | Dr Michael Stephen Wilberger, MD 345 Blackstone Blvd, Providence, RI 02906-4800 Ph: (401) 455-6200 |
News Archive
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce that its third annual pharmacogenetic conference will feature top-level presentations from players in all parts of the healthcare chain.
Researchers at the Center for BrainHealth® at the University of Texas at Dallas investigated the effects on the brain of concurrent cannabis and nicotine use, versus the use of solely cannabis and solely nicotine.
Children with autism may have lower quality handwriting and trouble forming letters compared to children without autism, according to a study published in the November 10, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.
Innovation doesn't come easy" says Steve Atkinson, Systagenix CEO "and neither do great brands, yet our team have been responsible for many innovations within this field over the last four decades. We are now introducing the world's first rapid point of care test in wound care to help clinicians choose the most appropriate dressings and therapies for their patients and monitor their efficacy over time.
GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).
› Verified 8 days ago
Dr. Dana Siperstein, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 167 Point St, Providence, RI 02903 Phone: 401-793-8808 Fax: 401-793-8851 | |
Giuseppe Salvatore D'amelio Iv, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 167 Point St, Providence, RI 02903 Phone: 401-793-8808 | |
Eugenie Atallah, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-606-2645 Fax: 401-606-4386 | |
Dr. Luisa Skoble, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5448 Fax: 401-444-6119 | |
Arnaldo A Berges, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Jane Brown 5s, Providence, RI 02903 Phone: 401-444-5448 Fax: 401-444-6119 | |
Sharath Ponnappa Puttichanda, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 345 Blackstone Blvd, Providence, RI 02906 Phone: 401-455-6346 Fax: 401-455-6532 | |
Loreen Phyllis Carol Pirnie, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5448 |